STAT
APRIL 20, 2024
STAT publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor here , or find the submission form at the end of any First Opinion essay.
The Guardian - Pharmaceutical Industry
APRIL 20, 2024
Pharmaceutical equipment firms are funding NHS staff and training while promoting sales Medical device companies are paying millions of pounds to hospitals in the UK to fund staff places, as well as training and awareness campaigns, while pushing sales of their products, including implants, heart valves and diagnostic equipment, a new report reveals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
APRIL 20, 2024
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from one supplier.
Pharmacy Times
APRIL 20, 2024
Retinoic acid, an active form of vitamin A, is crucial for the stem cells to depart lineage plasticity which get separated into hair cells or epidermal cells in vitro.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
APRIL 20, 2024
This chart shows the pharmaceutical companies with the most patents in United Kingdom.
Expert insights. Personalized for you.
250 
Let's personalize your content